24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
We look forward to exhibit at EuroMedLab 2021, the XXIV IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine in Munich 29th November to 1st December 2021.
We hope to see you at our booth #201 to discuss #DiagnosticEfficieny and to our products:
GCAL® Plasma and serum calprotectin
SARS-CoV-2 Total Antibody - Launch Q4 2021
NT-proBNP - Pre-Launch
Gentian is a Norwegian diagnostics company that makes assays for clinically relevant biomarkers available on high-throughput platforms, utilising the Particle-Enhanced Turbidimetric Immunoassay (PETIA) technology. The current portfolio and future pipeline of diagnostic reagents span areas of kidney disease, cardiac disease, inflammation, infection and veterinary medicine.
Our business growth is based on:
We manufacture reagents for both laboratories and industry partners. R&D, production, marketing and distribution are performed at our headquarters in Norway. Global operations are supported by subsidiaries in Sweden and the US, and through a representative office in China.
Direct sales channel
PETIA and proprietary nanoparticle technology
By leveraging both our expertise in Particle-Enhanced Turbidimetric Immunoassays (PETIA) and our proprietary nanoparticle technology, we develop immunoassays that enable users to transition from traditional low volume immunology platforms to fully automated clinical chemistry instruments.
We innovate diagnostic efficiency
We are constantly expanding our global market reach. For sharing a success story, please register for a meeting with us at IFCC EuroMedLab or send an email to firstname.lastname@example.org
Get in touch for more information
Interested in our reagents? Want to know more? Would you like to be our business partner? Please send an email to email@example.com, register for a meeting above or fill out the form below: